Refresh

Venus Remedies Ltd.

Price on BSE   03 Feb,09:20 LIVE
801.65
+8.65
(+1.09%)

© 2026 Rediff.com
  • Volume :
  • 91.00
  • Prev Close :
  • 793.00
  • Day's H/L (Rs.) :
  • 825.00 - 801.65
  • 52wk H/L (Rs.) :
  • 872.80 - 277.85
  • Mkt Cap (Rs. Cr) :
  • 1,074.22
Price on NSE   03 Feb,10:06 LIVE
790.00
+2.85
(+0.36%)

© 2026 Rediff.com
  • Volume :
  • 10,077.00
  • Prev Close :
  • 787.15
  • Day's H/L (Rs.) :
  • 826.50 - 788.00
  • 52wk H/L (Rs.) :
  • 839.95 - 277.95
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Venus Remedies Ltd.
PE Ratios
20.18
EPS (Rs.)
39.30
Sales (Rs. Cr)
179.95
Face Value (Rs.)
10
Net Profit Margin(%)
8.21
Last Bonus
-
Last Dividend(%)
30
Return on Average Equity
8.91

News for Venus Remedies Ltd.

Venus Remedies: Drugs Approved in Vietnam
Venus Remedies secures marketing authorisations for Methotrexate, Cefuroxime, Irinotecan in Vietnam. Expands export footprint in South Asia.
Nov 09, 2025 12:22
Venus Remedies Renews Ukrainian GMP Certification
Venus Remedies has renewed its GMP certification from Ukraine's State Service on Medicines and Drugs Control (SMDC), reinforcing its position in the Ukrainian market and expanding its reach into...
May 24, 2025 10:37
Venus Remedies Gets Marketing Nod for Sugammadex in Philippines
Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding...
Mar 04, 2025 13:05
Venus Remedies Partners with UK Firm to Develop MET-X for Drug-Resistant Infections
Venus Remedies has partnered with Infex Therapeutics to develop MET-X, an innovative metallo-beta-lactamase inhibitor, to tackle drug-resistant gram-negative bacteria in India. The partnership aims...
Feb 25, 2025 12:18
Venus Remedies Secures Market Authorization for Anticoagulant in Indonesia
Venus Remedies has received marketing authorization from Indonesia for its Enoxaparin, an anticoagulant, in pre-filled syringes. The approval reinforces the company's presence in Southeast Asia and...
Feb 10, 2025 18:06

More News for Venus Remedies Ltd. »

News for Pharmaceuticals and health care

Rupee Surges on India-US Trade Deal
Rupee jumps 119 paise to 90.30 against the US dollar after US tariffs on India were cut to 18%.
Feb 03, 2026 10:00
Sensex Soars on India-US Trade Deal
Sensex and Nifty jump after India and US agree to a trade deal. Tariffs on Indian goods to be reduced. Market sentiment boosted.
Feb 03, 2026 09:55
India-US Trade Deal: Semiconductor & Electronics Boost
India-US trade deal to boost electronics, semiconductor ecosystem. Reduced tariffs, increased cooperation in AI & data centers expected.
Feb 03, 2026 09:38
US-India Trade Deal: Farm Exports & Russia Counter
US leaders hail trade deal with India, boosting farm exports and countering Russian aggression. Key details and reactions inside.
Feb 03, 2026 08:45
India-US Trade Deal: Boost for Engineering Exports
India and US agree on trade deal lowering tariffs. EEPC India says engineering exports will benefit. Details awaited on product categories.
Feb 03, 2026 00:27

More News »

Top News

Rupee Surges on India-US Trade Deal
Rupee jumps 119 paise to 90.30 against the US dollar after US tariffs on India were cut to 18%.
Feb 03, 2026 10:00
Congress Demands Details on US, EU Trade Deals
Congress asks Modi govt to share details of US & EU trade deals with Parliament, raising concerns about farmer interests.
Feb 03, 2026 09:57
Sensex Soars on India-US Trade Deal
Sensex and Nifty jump after India and US agree to a trade deal. Tariffs on Indian goods to be reduced. Market sentiment boosted.
Feb 03, 2026 09:55
India-US Trade Deal: Boost for Manufacturing
India and US reach trade deal, reducing tariffs. A boost for Made in India, manufacturing, and economic cooperation. Details inside.
Feb 03, 2026 09:49
India-US Trade Deal: Semiconductor & Electronics Boost
India-US trade deal to boost electronics, semiconductor ecosystem. Reduced tariffs, increased cooperation in AI & data centers expected.
Feb 03, 2026 09:38

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com